FYARRO

Serial Number 88984193
Registration 6815686
700

Registration Progress

Application Filed
Aug 30, 2019
Under Examination
Sep 22, 2020
Approved for Publication
Jul 28, 2020
Published for Opposition
Jul 28, 2020
Registered
Aug 9, 2022

Trademark Image

FYARRO

Basic Information

Serial Number
88984193
Registration Number
6815686
Filing Date
August 30, 2019
Registration Date
August 9, 2022
Published for Opposition
July 28, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 9, 2022
Registration
Registered
Classes
005

Rights Holder

AADi Bioscience, Inc.

03
Address
2 Headquarters Plaza, East Building, 11t
Morristown, NJ 07960

Ownership History

AADi Bioscience, Inc.

Original Applicant
03
Pacific Palisades, CA

AADi Bioscience, Inc.

Owner at Publication
03
Pacific Palisades, CA

AADi Bioscience, Inc.

Original Registrant
03
Morristown, NJ

Legal Representation

Attorney
Aaron D. Hendelman

USPTO Deadlines

Next Deadline
1009 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-08-09)
Due Date
August 09, 2028
Grace Period Ends
February 09, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

43 events
Date Code Type Description Documents
Oct 24, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 24, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 24, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 24, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 24, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 9, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 9, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 6, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jul 5, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 1, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
May 6, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 6, 2022 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Apr 11, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 5, 2022 INCD O ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST Loading...
Apr 1, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 22, 2022 IUAF S USE AMENDMENT FILED Loading...
Mar 21, 2022 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Mar 21, 2022 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Mar 21, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 21, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 22, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 20, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 20, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 20, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 25, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 23, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 23, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 23, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 22, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 28, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 28, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 8, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 24, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 24, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 24, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 16, 2020 ALIE A ASSIGNED TO LIE Loading...
Jun 8, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 11, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 11, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 11, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 4, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 12, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 3, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in oncology; pharmaceutical preparations for the treatment of physiological diseases
First Use Anywhere: Feb 21, 2022
First Use in Commerce: Feb 21, 2022

Classification

International Classes
005